Page 142 - GPD-3-4
P. 142

Gene & Protein in Disease                                      A pyroptosis-related gene signature in myeloma




                         A                     B                        C










                         D                       E











                         F                      G                       H












            Figure 8. In vitro validation of the expression of 9 PRGs in MM cells treated with the pyroptosis-inducing agent etoposide. (A-H) The mRNA expressions
            of CHMP2A (A), CHMP3 (B), NOD2 (C), PLCG1 (D), FOXO3 (E), CASP3 (F), CASP8 (G), and CHMP6 (H) in the MM cells treated with varying
            concentrations of etoposide.
            Abbreviations: MM: Multiple myeloma; PRGs: Pyroptosis-related genes.

            4,5-bisphosphate  (PIP2)  into  diacylglycerol  (DAG)  and   understanding of the roles of pyroptosis in MM prognosis,
            inositol trisphosphate (IP3), both of which are critical in   thereby facilitating the development of precision medicine.
            controlling inflammasome activation and pyroptosis.
                                                         46
            However, given that MM cells undergo pyroptosis mainly   Acknowledgments
            through GSDME- but not GSDMD-mediated pathway, the   None.
            specific roles of these genes in MM cell pyroptosis should
            be further investigated.                           Funding

            5. Conclusion                                      This project was partly supported by the National Key Research
                                                               and Development Program of China (#2022YFC2705003),
            The present study establishes a novel PRG-based    National Natural Science Foundation of China (#82170176),
            independent prognostic model that is powerful to predict   and Guangzhou Medical University Discipline Construction
            the overall survival of MM patients and effective for   Funds (Basic Medicine) (#JCXKJS2022A05).
            distinguishing among MM patients with different disease
            risk profile. However, our PRG signature set does not   Conflict of interest
            encompass genes related to karyotype or mutations in the   Xinliang Mao is the Editorial Board Member of this
            IPSS system, making it a novel and effective model for   journal but was not in any way involved in the editorial
            stratifying MM patients and predicting prognosis, that is   and peer-review process conducted for this paper, directly
            not governed by the current IPSS system’s classification   or indirectly. Separately, other authors declared that they
            and not restricted by karyotype profiles. Moreover, we also   have no known competing financial interests or personal
            found several key genes that might play key roles in MM cell   relationships that could have influenced the work reported
            pyroptosis. Our future work will continue to deepen our   in this paper.


            Volume 3 Issue 4 (2024)                         13                              doi: 10.36922/gpd.4534
   137   138   139   140   141   142   143   144   145   146   147